GDI2 and hepatocellular carcinoma: On the contrary, HCC patients with low GDI2 expression could strongly improve their OS rate especially when they were in clinicopathological subtypes as T1 Stage, pathologic Stage I/II, retarded fibrosis with negative lymph nodes, without metastasis and vascular invasion (*P < 0.05) (Figure 6).